Krystallenia Paniskaki
Overview
Explore the profile of Krystallenia Paniskaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
369
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rohn H, Elischer F, Larbig L, Jansen S, Schramm S, Otte M, et al.
HLA
. 2024 Dec;
104(6):e15799.
PMID: 39711218
HLA-G, an important immune-checkpoint (IC) molecule that exerts inhibitory signalling on immune effector cells, has been suggested to represent a key player in regulating the immune response to Severe Acute...
2.
Paniskaki K, Goretzki S, Anft M, Konik M, Meister T, Pfaender S, et al.
Pediatr Allergy Immunol
. 2023 Dec;
34(12):e14060.
PMID: 38146118
Background: A proportion of the convalescent SARS-CoV-2 pediatric population presents nonspecific symptoms, mental health problems, and a reduction in quality of life similar to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and...
3.
Paniskaki K, Goretzki S, Anft M, Konik M, Lechtenberg K, Vogl M, et al.
BMC Infect Dis
. 2023 Nov;
23(1):818.
PMID: 37993788
Cross-reactive cellular and humoral immunity can substantially contribute to antiviral defense against SARS-CoV-2 variants of concern (VOC). While the adult SARS-CoV-2 cellular and humoral immunity and its cross-recognition potential against...
4.
Westmeier J, Brochtrup A, Paniskaki K, Karakoese Z, Werner T, Sutter K, et al.
Front Immunol
. 2023 Nov;
14:1236374.
PMID: 37946732
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused millions of COVID-19 cases and deaths worldwide. Severity of pulmonary pathologies and poor prognosis were reported to be associated with the activation...
5.
Doevelaar A, Bachmann M, Holzer B, Seibert F, Rohn B, Zgoura P, et al.
Sci Rep
. 2023 Jun;
13(1):10501.
PMID: 37380654
It has recently been shown that von Willebrand factor (VWF) multimers contribute to immunothrombosis in Coronavirus disease 2019 (COVID-19). Since COVID-19 is associated with an increased risk of autoreactivity, the...
6.
Paniskaki K, Konik M, Anft M, Heidecke H, Meister T, Pfaender S, et al.
Front Microbiol
. 2023 Jun;
14:1196721.
PMID: 37333646
The role of adaptive SARS-CoV-2 specific immunity in post-acute sequelae of COVID-19 (PASC) is not well explored, although a growing population of convalescent COVID-19 patients with manifestation of PASC is...
7.
Paniskaki K, Konik M, Anft M, Meister T, Marheinecke C, Pfaender S, et al.
Front Immunol
. 2022 Nov;
13:1031254.
PMID: 36389833
Emerging variants of concern (VOC) raise obstacles in shaping vaccination strategies and ending the pandemic. Vaccinated SARS-CoV-2 convalescence shapes the current immune dynamics. We analyzed the SARS-CoV-2 VOC-specific cellular and...
8.
Anft M, Paniskaki K, Giglio T, Wellenkotter J, Blazquez-Navarro A, Meister T, et al.
Kidney Int
. 2022 Nov;
103(1):223-225.
PMID: 36332726
No abstract available.
9.
Blazquez-Navarro A, Mittmann L, Thieme C, Anft M, Paniskaki K, Doevelaar A, et al.
J Nephrol
. 2022 Jul;
36(1):199-202.
PMID: 35779233
No abstract available.
10.
Paniskaki K, Anft M, Thieme C, Skrzypczyk S, Konik M, Dolff S, et al.
Transplant Proc
. 2022 Apr;
54(6):1455-1464.
PMID: 35489983
Background: Immune responses to seasonal endemic coronaviruses might have a pivotal role in protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Those SARS-CoV-2-crossreactive T cells were recently described in...